Christian Henrik Tange
Director/Board Member at KDev Investments AB
Profile
Christian Henrik Tange is currently a Director at KDev Investments AB.
He was previously a Chairman at Dilafor AB, Director at Promimic AB, Director at Xspray Pharma AB, and Director at KDev Oncology AB.
From 2014 to 2017, he served as the Chief Financial Officer at Karolinska Development AB (Private Equity) and from 2018 to 2020, he was the Chief Financial Officer at Agillic A.
He also served as the Chief Financial Officer at Karolinska Development AB from 2014 to 2017.
Prior to that, he was the Chief Financial Officer at AGC Biologics A from 2003 to 2012 and a Business Controller at Warner Lambert Nordic AB from 1997 to 2000.
He received his undergraduate and graduate degrees from Copenhagen Business School.
Christian Henrik Tange active positions
| Companies | Position | Start |
|---|---|---|
KDev Investments AB
 KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Director/Board Member | - |
Former positions of Christian Henrik Tange
| Companies | Position | End |
|---|---|---|
| AGILLIC A/S | Director of Finance/CFO | 2020-08-31 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Director of Finance/CFO | 2017-11-29 |
| KAROLINSKA DEVELOPMENT AB | Director of Finance/CFO | 2017-08-28 |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Director of Finance/CFO | - |
| Warner Lambert Nordic AB | Corporate Officer/Principal | - |
Training of Christian Henrik Tange
| Copenhagen Business School | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| AGILLIC A/S | Technology Services |
| PROMIMIC AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| KAROLINSKA DEVELOPMENT AB | Finance |
| Private companies | 6 |
|---|---|
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
AGC Biologics A/S
AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Health Technology |
Dilafor AB
 Dilafor AB Pharmaceuticals: MajorHealth Technology Dilafor AB develops pharmaceutical products from heparin derivatives with low anticoagulant activity. It investigates document and exploits the pharmacological properties of derivatives in the field of obstetrics. The company was founded by Gunvor Ester Ekman-Ordeberg, Hans-Peter Ekre, Per-Olov Eriksson, Per Giléus, Kjell Gunnarsson, Erik Yngve Holmer, Göran Kvist, Ulf Lindahl, Anders Malmström, Tore Mellstrand, Johan Rasin, and Mats Wahlgren in 2003 and is headquartered in Solna, Sweden. | Health Technology |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Commercial Services |
KDev Investments AB
KDev Investments AB BiotechnologyHealth Technology KDev Investments AB engages in research, sales, and development in the fields of medicine, biotechnology, pharmaceuticals, and medical technology. It also owns and manages investments of companies in the fields of medicine. Its portfolio will include both early and clinical stage pharmaceutical assets, as well as some technology assets. The company was founded on January 10, 2012 and is headquartered in Solna, Sweden. | Health Technology |
| Warner Lambert Nordic AB |
- Stock Market
- Insiders
- Christian Henrik Tange
